SPY411.49+2.97 0.73%
DIA337.86+2.73 0.81%
IXIC13,900.19+70.88 0.51%

BRIEF-Spectrum Pharmaceuticals Provides Update On Rolontis (Eflapegrastim) Pre-Approval Inspection

· 03/16/2021 07:26
BRIEF-Spectrum Pharmaceuticals Provides Update On Rolontis (Eflapegrastim) Pre-Approval Inspection

- Spectrum Pharmaceuticals Inc SPPI.O:

  • SPECTRUM PHARMACEUTICALS INC - FDA HAS SCHEDULED PRE-APPROVAL INSPECTION AT ROLONTIS® (EFLAPEGRASTIM) MANUFACTURING SITE IN MAY 2021

Source text for Eikon: ID:nBw9Rb7jxa

Further company coverage: SPPI.O


((Reuters.Briefs@thomsonreuters.com;))